A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.
Consensus-based guidelines supported by the literature are presented on the role of prophylactic administration of factor VIII concentrate in children and adults with severe haemophilia A. The timing of initiation of prophylaxis, the choice of prophylactic regimen, monitoring, management of breakthrough bleeding and education of the patient and family are discussed.
Richards
Michael
M
St. James's University Hospital, Leeds, UK. michael.richards@leedsth.nhs.uk
Williams
Michael
M
Chalmers
Elizabeth
E
Liesner
Ri
R
Collins
Peter
P
Vidler
Vicky
V
Hanley
John
J
D000328:Adult; D002648:Child; D003029:Coagulants / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods; D019317:Evidence-Based Medicine; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D055815:Young Adult
D003029:Coagulants; D005169:Factor VIII